Boston Scientific Corp (BSX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2003 | 03-2003 | 12-2002 | 09-2002 | 06-2002 | |
| Sales | 854,000 | 807,000 | 814,000 | 722,000 | 708,000 |
| Cost of Goods | 235,000 | 226,000 | 227,000 | 211,000 | 225,000 |
| Gross Profit | 619,000 | 581,000 | 587,000 | 511,000 | 483,000 |
| Operating Expenses | 446,000 | 426,000 | 430,000 | 265,000 | 401,000 |
| Operating Income | 173,000 | 155,000 | 157,000 | 246,000 | 82,000 |
| Interest Expense | 12,000 | 11,000 | 11,000 | 10,000 | 10,000 |
| Other Income | 0 | -4,000 | -3,000 | -1,000 | -18,000 |
| Pre-tax Income | 161,000 | 140,000 | 143,000 | 235,000 | 54,000 |
| Income Tax | 47,000 | 43,000 | 38,000 | 74,000 | 29,000 |
| Net Income Continuous | 114,000 | 97,000 | 105,000 | 161,000 | 25,000 |
| Net Income | $114,000 | $97,000 | $105,000 | $161,000 | $25,000 |
| EPS Basic Total Ops | 0.14 | 0.12 | 0.13 | 0.20 | 0.03 |
| EPS Basic Continuous Ops | 0.14 | 0.12 | 0.13 | 0.20 | 0.03 |
| EPS Diluted Total Ops | 0.13 | 0.11 | 0.13 | 0.19 | 0.03 |
| EPS Diluted Continuous Ops | 0.13 | 0.11 | 0.13 | 0.19 | 0.03 |
| EBITDA(a) | $173,000 | $155,000 | $157,000 | $246,000 | $82,000 |